Adverse drug reaction update.
Increasing numbers of articles on adverse drug reactions are published in a wide range of medical journals. To help keep you up-to-date with the latest advances worldwide on all aspects of adverse drug reactions, this section of the journal brings you information selected from the drug safety alerting service Reactions Weekly. The following reports are selected from the latest issues, summarizing the most important clinical studies, adverse reaction news, and expert opinion pieces published across a broad range of literature sources.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D016642:Bupropion; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D000075202:Contraindications; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects; D008297:Male; D011753:Pyrones / Q000009:adverse effects; D011994:Recombinant Proteins; D012202:Reye Syndrome / Q000209:etiology; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011753:Pyrones; D011994:Recombinant Proteins; D016642:Bupropion; D001241:Aspirin; C011889:kavain